PTPN11 and cancer: E76 is the most frequently mutated site of SHP2 in human cancers and the mutations disrupt the inhibition of PTP domain by the N-SH2, while R498 mutations in SHP2’s PTP domain are also commonly observed and associated with LEOPARD syndrome [189].